R J Kreitman Selected Research

R J Kreitman Research Topics

Disease

17	Neoplasms (Cancer) 01/2022 - 02/2000
5	Hematologic Neoplasms (Hematological Malignancy) 12/2001 - 04/2000
3	Hairy Cell Leukemia 01/2017 - 02/2000
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2007 - 02/2000
2	Glioma (Gliomas) 01/2002 - 06/2000
2	Ovarian Neoplasms (Ovarian Cancer) 07/2001 - 07/2000
2	Leukemia 12/2000 - 04/2000
2	Necrosis 12/2000 - 06/2000
1	Disease Progression 01/2022
1	Anaplastic Thyroid Carcinoma 01/2022
1	Carcinogenesis 01/2017
1	Multiple Myeloma 01/2007
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2007
1	Weight Loss (Weight Reduction) 07/2006
1	Acute Erythroblastic Leukemia (Erythroleukemia) 07/2006
1	Medulloblastoma 01/2002
1	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 12/2001
1	Thrombocytopenia (Thrombopenia) 12/2001
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 08/2001
1	Hypoalbuminemia 07/2001
1	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 06/2001
1	Hodgkin Disease (Hodgkin's Disease) 06/2001
1	Lymphoma (Lymphomas) 12/2000
1	Autoimmune Diseases (Autoimmune Disease) 09/2000
1	Ovarian Epithelial Carcinoma 07/2000
1	Malignant Mesothelioma 07/2000
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 07/2000
1	Carcinoma (Carcinomatosis) 07/2000
1	Glioblastoma (Glioblastoma Multiforme) 06/2000
1	Myeloid Leukemia (Leukemia, Myelocytic) 04/2000
1	Cardiomyopathies (Cardiomyopathy) 04/2000
1	Diarrhea 04/2000
1	Fever (Fevers) 04/2000
1	B-Cell Leukemia (Leukemia, B Cell) 04/2000
1	Diphtheria 04/2000
1	Breast Neoplasms (Breast Cancer) 03/2000
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 03/2000

Drug/Important Bio-Agent (IBA)

11	Immunotoxins (Immunotoxin)IBA 01/2017 - 02/2000
8	Proteins (Proteins, Gene)FDA Link 01/2017 - 02/2000
6	ExotoxinsIBA 07/2006 - 03/2000
5	B3(Fv)-PE38KDEL recombinant immunotoxinIBA 12/2001 - 02/2000
3	Diphtheria ToxinIBA 12/2001 - 04/2000
2	Interleukin-2 (IL2)IBA 01/2002 - 12/2001
2	Interleukin-4 Receptors (Interleukin 4 Receptor)IBA 01/2002 - 03/2000
2	Interleukin-4 (Interleukin 4)IBA 01/2002 - 06/2000
2	Recombinant ProteinsIBA 01/2002 - 04/2000
2	LigandsIBA 09/2001 - 02/2000
2	Transaminases (Aminotransferases)IBA 07/2001 - 04/2000
2	DNA (Deoxyribonucleic Acid)IBA 06/2001 - 07/2000
2	Monoclonal AntibodiesIBA 04/2000 - 04/2000
1	dabrafenibIBA 01/2022
1	trametinibIBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2017
1	Bcl-2-Like Protein 11IBA 01/2017
1	Doxorubicin (Adriamycin)FDA LinkGeneric 07/2006
1	Messenger RNA (mRNA)IBA 01/2002
1	Cytotoxins (Cytolysins)IBA 01/2002
1	Interleukin-13IBA 01/2002
1	denileukin diftitox (Ontak)FDA Link 12/2001
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 12/2001
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 08/2001
1	purineIBA 07/2001
1	Cladribine FDA LinkGeneric 07/2001
1	RFB4(dsFv)-PE38 recombinant immunotoxinIBA 07/2001
1	Single-Chain AntibodiesIBA 06/2001
1	Complementary DNA (cDNA)IBA 06/2001
1	Peptide Elongation Factor 2 (EF-2)IBA 07/2000
1	Surface Antigens (Surface Antigen)IBA 07/2000
1	CaspasesIBA 07/2000
1	Differentiation AntigensIBA 07/2000
1	MesothelinIBA 07/2000
1	Glycosylphosphatidylinositols (Glycosyl-Phosphatidylinositol)IBA 07/2000
1	Membrane Glycoproteins (Membrane Glycoprotein)IBA 07/2000
1	Interleukin-2 Receptor alpha SubunitIBA 07/2000
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 07/2000
1	CytokinesIBA 06/2000
1	GadoliniumIBA 06/2000
1	InterleukinsIBA 06/2000
1	interleukin-4-Pseudomonas exotoxinIBA 06/2000
1	Interleukin-3 (Interleukin 3)IBA 04/2000
1	Interleukin-3 Receptors (Interleukin 3 Receptor)IBA 04/2000
1	AntigensIBA 04/2000
1	DisulfidesIBA 04/2000
1	ThymidineIBA 04/2000
1	antitac(FV)-PE38 recombinant immunotoxinIBA 04/2000
1	IgG Receptors (Fc gamma RI)IBA 03/2000
1	Interleukin-2 Receptors (IL 2 Receptor)IBA 03/2000
1	Peptides (Polypeptides)IBA 02/2000

Therapy/Procedure

7	Therapeutics 01/2022 - 02/2000
2	Drug Therapy (Chemotherapy) 12/2001 - 07/2001
1	Catheters 06/2000
1	Salvage Therapy 04/2000